NEU 0.35% $20.17 neuren pharmaceuticals limited

ROW Rights, page-103

  1. 1,243 Posts.
    lightbulb Created with Sketch. 307
    Is it within the realm of possibilities that NEU announce an extension to ROW exclusivity for ACAD? I don't recall reading that the period was capped at 3 months, rather that there was a 3 month minimum for ACAD.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.